Anti-CD134 [A10-F]

Catalogue Number: AB02228-3.0-ABA

Manufacturer:Vector Laboratories, Inc (ABA)
Type:Recombinant Monoclonal
Alias:OX40; OX-40; OX40L receptor; TNFRSF4; Tumor necrosis factor receptor superfamily member 4; ACT35 antigen; TAX transcriptionally-activated glycoprotein 1 receptor
Shipping Condition:Blue Ice
Unit(s): 200 ug
Host name: Mouse
Clone: A10-F
Isotype: IgG2b
Immunogen: The original antibody was generated by immunizing mice with a soluble OX40/Fcγ1 as an immunogen, combined with Freund's adjuvant (1:1) and administered to two six-week-old A/J mice.
Application: ELISA, FC, Blk

Additional Text

Gene Name

TNFRSF4

Gene ID

7293

Uniprot ID

P43489

Purification

Purified

Antibody Clonality

Recombinant Monoclonal

Storage Note

Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C.

Application Notes

This antagonist antibody is a humanized version of the original murine parent antibody A10. The binding specificity of this antibody to OX40 was determined by ELISA and flow cytometric techniques. Naive CD4+ T-cell assay was used to test the ability to inhibit cytokine production, proliferation, and to induce apoptosis in human CD4+ T-cells. A10-F inhibited cytokine release (IL-2/IL-5/IL-13) and CD4+ T-cells proliferation to the same level as its murine parent. A10-F was also tested for its antagonistic activities like inhibiting the proliferation and cytokine release of Th1 primed T-cells, Th2 primed T-cells and Th17 cells in the presence of irradiated OX40L transfected L-cells or parental L-cells. Under Th1 conditions, A10-F inhibited the production of IL-2, IL-5, IL-13 cytokines and cell proliferation. Under Th2 conditions, A10-F showed an antagonistic effect on activated CD4+ T-cells by inhibiting their proliferation and cytokine release (IL-2, IL-5, and IL-13). With Th17 cells, A10-F increased apoptosis in a dose dependent manner. Cell proliferation and cytokine production in Th2 cells primed with TSLP-activated myeloid CD11c+ dendritic cells (DCs) was inhibited in the presence of A10-F. It also further caused significant increase in apoptosis and a lower expression of Survivin. A10-F was also tested for its antagonistic activities and the ability to inhibit the proliferation and cytokine production of Th1 primed T-cells in the presence of LPS-activated DCs. Here also A10-F inhibited the IL-2, IFN-γ, and TNF-α cytokines production and cell proliferation (US20100136030).

Short Description

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.